What biomarkers or patient characteristics do you feel best predict response to B cell depleting therapies in a patient with Sjogren's?
Community PollStarted
What biomarkers or patient characteristics do you feel best predict response to B cell depleting therapies in a patient with Sjogren's?
80 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Rheumatology · University of California, Berkeley and San Francisco
Answered on
At present, it may depend on the Sjogren's phenotype being treated with B-cell depleting therapies. If it is vasculitis with or without cryo, cryoglobulins, rheumatoid factor, and complements are helpful, along with inflammatory markers (ESR/CRP). I also note the level of total IgG, if elevated, may...
Join for free or sign in to see the full answer
Mednet Member
Rheumatology · Duke Univeristy
Answered on
At this point, I do not think there is a consensus about clinically available biomarkers that reliably predict response rate to B-cell-depleting therapies in SjD. There are some research studies pointing to changes in flow cytometry, immunohistopathology, and cytokine production, but these research ...
Join for free or sign in to see the full answer